Human 18 kDa phosphotyrosine protein phosphatase (ACP1) polymorphism: Studies of rare variants provide evidence that substitutions within or near alternatively spliced exons affect splicing result

Annals of Human Genetics

Volumn 64, Issue 2, 2000, Pages 107-116

  Rudbeck, L ^a   Dissing, Jørgen ^a,c   Lazaruk, K D A ^b   Sensabaugh, G ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Institute of Forensic Medicine   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BASE; PROTEIN TYROSINE PHOSPHATASE;

ALTERNATIVE RNA SPLICING; ARTICLE; DNA POLYMORPHISM; ENZYME POLYMORPHISM; EXON; HUMAN; HUMAN CELL; NUCLEIC ACID BASE SUBSTITUTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

ALTERNATIVE SPLICING; BASE SEQUENCE; DNA; EXONS; HUMANS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PROTEIN-TYROSINE-PHOSPHATASE;

MAMMALIA;

EID: 0033915885     PISSN: 00034800     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0003480000007995     Document Type: Article

References (44)

1. Blake, N. M., Kirk, R. L., Barnes, K. R. & Thompson, J. M. (1973). Expression of human red cell acid phosphatase activity in placenta and other tissues. Jpn. J. Hum. Genet. 18, 10-23.
2. Bryson, G. L. M., Massa, H., Trask, B. J. & Vanetten, R. L. (1995). Gene structure, sequence, and chromosomal localization of the human red cell-type low-molecular-weight acid phosphotyrosyl phosphatase gene. ACP1. Genomics 30, 133-140.
3. Calvert, R. J., Weghorst, C. M. & Buzard, G. S. (1995). PCR amplification of silver-stained SSCP bands from cold SSCP gels. Biotechniques 18, 782-786.
4. Chory, J. & Baldwin, A. S., Jr. (1994). Resolution and recovery of small DNA fragments. In Current Protocols in Molecular Biology (eds. Ausubel, F. M., Brent, R., Kingston, R. E. et al.), pp. 2.7.1-2.7.8. New York: John Wiley & Sons.
5. Cooper, T. A. (1992). In citro splicing of cardiac troponin T precursors. Exon mutations disrupt splicing of the upstream intron. J. Biol. Chem. 267, 5330-5338.
6. Cooper, T. A. & Mattox, W. (1997). The regulation of splice-site selection, and its role in human disease. Am. J. Hum. Genet. 61, 259-266.
7. Cooper, T. A. & Ordahl, C. P. (1989). Nucleotide substitutions within the cardiac troponin T alternative exon disrupt pre-mRNA alternative splicing. Nucleic Acids Res. 17, 7905-7921.
8. Coulter, L. R., Landree, M. A. & Cooper, T. A. (1997). Identification of a new class of exonic splicing enhancers by in vivo selection. Mol Cell Biol. 17, 2143-2150.
9. Dissing, J. (1987). Immunochemical characterization of human red cell acid phosphatase isozymes. Biochem. Genet. 25, 901-917.
10. Dissing, J. & Christiansen, D. (1996). Detection of the ABO, GC, ACP1 and HLA-DQA1 polymorphisms at the DNA level using PCR and SSCP. In Advances in Forensic Haemogenetics (eds. A. Carracedo, B. Brinkmann & W. Bär), pp. 407-409. Berlin: Springer.
11. Dissing, J., Dahl, O. & Svensmark, O. (1979). Phosphonic and arsonic acids as inhibitors of human red cell acid phosphatase and their use in affinity chromatography. Biochim. Biophys. Acta 569, 159-176.
12. Dissing, J. & Johnsen, A. H. (1992). Human red cell acid phosphatase (ACP1) - the primary structure of the two pairs of isozymes encoded by the ACP1*A and ACP1*C alleles. Biochim. Biophys. Acta 1121, 261-268.
13. Dissing, J., Johnsen, A. H. & Sensabaugh, G. F. (1991). Human red cell acid phosphatase (ACP1) - the amino acid sequence of the 2 isozymes Bf and Bs encoded by the ACP1*B Allele. J. Biol. Chem. 266, 20619-20625.
14. Dissing, J., Rangaard, B. & Christensen, U. (1993). Activity modulation of the fast and slow isozymes of human cytosolic low-molecular-weight acid phosphatase (ACP1) by purines. Biochim. Biophys. Acta 1162, 275-282.
15. Dissing, J. & Sensabaugh, G. F. (1987). Human red cell acid phosphatase (ACP1): evidence for differences in the primary structure of the two isozymes encoded by the ACP1*B allele. Biochem. Genet. 25, 919-927.
16. Dissing, J. & Svensmark, O. (1976). Human red cell acid phosphatase: quantitative evidence of a silent gene PO and a Danish population study. Hum. Hered. 26, 43-58.
17. Dissing, J. & Svensmark, O. (1990). Human red cell acid phosphatase: purification and properties of the A, B and C isozymes. Biochim. Biophys. Acta 1041, 232-242.
18. Elrick, L. L., Humphrey, M. B., Cooper, T. A. & Berget, S. M. (1998). A short sequence within two purine-rich enhancers determines 5′ splice site specificity. Mol. Cell Biol. 18, 343-352.
19. Evans, B., Tishmack, P. A., Pokalsky, C., Zhang, M. & Vanetten, R. L. R. (1996). Site directed mutagenesis, kinetic, and spectroscopic studies of the p loop residues in a low molecular weight protein tyrosine phosphatase. Biochemistry 35, 13609-13617.
20. Ferguson-Smith, M. A., Newman, B. F., Ellis, P. M., Thomson, D. M. G. & Riley, I. D. (1973). Assignment by deletion of human red cell acid phosphatase gene locus to the short arm of chromosome 2. Nat. New Biol. 243, 271-274.
21. Golden, V. L. & Sensabaugh, G. F. (1986). Phenotypic variation in the phosphotransferase activity of human red cell acid phosphatase (ACP1). Hum. Genet. 72, 340-343.
22. Hara, F., Suzuki, T., Saito, M., Hikino, T., Fukushima, T., Oyama, T., Fukuda, T. & Nakajima, T. (1994). Non-isotopic single strand conformation polymorphism (PCR-SSCP) with subsequent direct sequencing after silver staining. Pathol. Int. 44, 815-816.
23. Hopkinson, D. A., Spencer, N. & Harris, H. (1963). Red cell acid phosphatase variants: a new human polymorphism. Nature 199, 969-971.
24. Hopkinson, D. A., Spencer, N. & Harris, H. (1964). Genetical studies on human red cell acid phosphatase. Am. J. Hum. Genet. 16, 141-154.
25. Lazaruk, K. D. A. (1995). Molecular genetics of human red cell acid phosphatase. University of California, Berkeley, Ph.D dissertation.
26. Lazaruk, K. D. A., Dissing, J. & Sensabaugh, G. F. (1993). Exon structure at the Human Acp1 locus supports alternative splicing model for f-isozyme and s-isozyme generation. Biochem. Biophys. Res. Commun. 196, 440-446.
27. Libri, D., Goux-Pelletan, M., Brody, E. & Fiszman, M. Y. (1990). Exon as well as intron sequences are cis-regulating elements for the mutually exclusive alternative splicing of the beta tropomyosin gene. Mol. Cell. Biol. 10, 5036-5046.
28. Ligtenberg, M. J., Gennissen, A. M., Vos, H. L. & Hilkens, J. (1991). A single nucleotide polymorphism in an exon dictates allele dependent differential splicing of episialin mRNA. Nucleic Acids Res. 19, 297-301.
29. Liu, H. X., Zhang, M. & Krainer, A. H. (1998). Identification of functional exonic splicing enhancer motifs recognized by individual SR proteins. Genes Dev. 12, 1998-2012.
30. Liu, W., Qian, C. & Francke, U. (1997). Silent mutation induces exon skipping of fibrillin-1 gene in Marfan syndrome. Nat. Genet. 16, 328-329.
31. Mansfield, E. & Sensabaugh, G. F. (1978). Red cell acid phosphatase: modulation of activity by purines. In The red cell (ed. G. J. Brewer), pp. 233-247. New York: Allan R. Liss.
32. Orita, M., Simiki, Y., Sekiya, T. & Hayashi, K. (1989). Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5, 874-879.
33. Roychoudhury, A. K. & Nei, M. (1988). Human polymorphic genes world distribution. Oxford University Press.
34. Rudbeck, L. & Dissing, J. (1998). Rapid, simple alkaline extraction of human genomic DNA from whole blood, buccal epithelial cells, semen and forensic stains for PCR. Biotechniques 25, 588-90, 592.
35. Schaal, T. D. & Maniatis, T. (1999). Multiple distinct splicing enhancers in the protein-coding sequences of a constitutively spliced pre-mRNA. Mol. Cell Biol. 19, 261-273.
36. Sensabaugh, G. F. & Golden, V. L. (1978). Phenotype dependence in the inhibition of red cell acid phosphatase (ACP) by Folates. Am. J. Hum. Genet. 30, 553-560.
37. Spencer, N., Hopkinson, D. A. & Harris, H. (1964). Quantitative differences and gene dosage in the human red cell acid phosphatase polymorphism. Nature 201, 299-300.
38. Steingrimsdottir, H., Rowley, G., Dorado, G., Cole, J. & Lehmann, A. R. (1992). Mutations which alter splicing in the human hypoxanthine-guanine phosphoribosyltransferase gene. Nucleic Acids Res. 20, 1201-1208.
39. Sun, Q., Mayeda, A., Hampson, R. K., Krainer, A. R. & Rottman, F. M. (1993). General splicing factor SF2/AS-F promotes alternative splicing by binding to an exonic splicing enhancer. Genes Dev. 7, 2598-2608.
40. Swallow, D. M., Povey, S. & Harris, H. (1973). Activity of the 'red cell' acid phosphatase locus in other tissues. Ann. Hum. Genet. 37, 31-38.
41. Sørensen, S. A. (1975). Report and characterization of a new variant, EB, of human red cell acid phosphatase. Am. J. Hum. Genet. 27, 100-109.
42. Tacke, R. & Manley, J. L. (1995). The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities. EMBO J. 14, 3540-3551.
43. Wakamatsu, N., Kobayashi, H., Miyatake, T. & Tsuji, S. (1992). A novel exon mutation in the human beta-hexosaminidase beta subunit gene affects 3′ splice site selection. J. Biol. Chem. 267, 2406-2413.
44. Watakabe, A., Tanaka, K. & Shimura, Y. (1993). The role of exon sequences in splice site selection. Genes Dev. 7, 407-418.